ClinicalTrials.gov
ClinicalTrials.gov Menu

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00968357
Recruitment Status : Completed
First Posted : August 31, 2009
Last Update Posted : June 8, 2012
Sponsor:
Information provided by (Responsible Party):
SciClone Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2011
  Actual Study Completion Date : January 2011